Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation, 19717-19718 [2012-7759]

Download as PDF 19717 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 4, 2012, Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company manufactures a product containing morphine in the United States. The company exports this product to customers around the world, including in Europe. The company has been asked to ensure that its product sold to European customers meets standards established by the European Pharmacopeia, which is administered by the Directorate for the Quality of Medicines (EDQM). In order to ensure that its product will meet European specifications, the company seeks to import morphine supplied by EDQM to use as reference standards. This is the sole purpose for which the company will be authorized by DEA to import morphine. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic class of controlled substance may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 2, 2012. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. VerDate Mar<15>2010 17:42 Mar 30, 2012 Jkt 226001 Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–7755 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration Mallinckrodt LLC By Notice dated January 23, 2012, and published in the Federal Register on January 31, 2012, 77 FR 4831, Mallinckrodt LLC, 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Phenylacetone (8501) .................. Coca Leaves (9040) ..................... Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) II II II II The company plans to import the listed controlled substances to manufacture bulk controlled substances for distribution to its customers, and for research and analytical standards. The company has withdrawn its application for registration to import the following drug codes: Methylphenidate (1724), Oxycodone (9143), Hydromorphone (9150), Hydrocodone (9193), Morphine (9300), and Fentanyl (9801). Comments and requests for hearings on applications to import narcotic raw material are not appropriate, 72 FR 3417 (2007). Regarding all other basic classes of controlled substances, no comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Mallinckrodt LLC, to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Mallinckrodt LLC to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–7758 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 17, 2012, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug 4-methyl-N-methylcathinone (1248). 3,4-methylenedioxypyrovalerone (7535). 3,4-methylenedioxy-Nmethylcathinone (7540). Desomorphine (9055) ................... Schedule I I I I The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 1, 2012. E:\FR\FM\02APN1.SGM 02APN1 19718 Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 USC § 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. [FR Doc. 2012–7759 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration, Norac Inc. By Notice dated December 20, 2011, and published in the Federal Register on December 29, 2011, 76 FR 81979, Norac Inc., 405 S. Motor Avenue, Azusa, California 91702–3232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–7750 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P mstockstill on DSK4VPTVN1PROD with NOTICES With regard to Gamma Hydroxybutyric Acid (2010), Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the company manufactures these controlled substances in bulk solely for domestic distribution within the United States to customers engaged in dosage-form manufacturing. With regard to Nabilone (7379) only, the company presently manufactures a small amount of this controlled substance in bulk solely to conduct manufacturing internal process development. It is the company’s intention once the manufacturing process is refined to the point that its Nabilone bulk product is available for commercial use, the company will export the controlled substance in bulk solely to customers engaged in dosageform manufacturing outside the United States. The company is aware of the requirement to obtain a DEA registration as an exporter to conduct this activity. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Norac, VerDate Mar<15>2010 17:42 Mar 30, 2012 Jkt 226001 Signed at Washington, DC, this 22nd day of March 2012. Elliott S. Kushner, Certifying Officer, Office of Trade Adjustment Assistance. [FR Doc. 2012–7795 Filed 3–30–12; 8:45 am] BILLING CODE 4510–FN–P Employment and Training Administration DEPARTMENT OF LABOR I I II II II All workers from Dow Jones & Company, Inc., Dow Jones Content Services, including on-site workers from Aerotek, Princeton, New Jersey, who became totally or partially separated from employment on or after February 13, 2010, through January 26, 2014, and all workers in the group threatened with total or partial separation from employment on date of certification through two years from the date of certification, are eligible to apply for adjustment assistance under Chapter 2 of Title II of the Trade Act of 1074, as amended. DEPARTMENT OF LABOR [TA–W–81,045] Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Methamphetamine (1105) ............ Pentobarbital (2270) ..................... Nabilone (7379) ............................ location of Dow Jones & Company, Inc., Dow Jones Content Services. The amended notice applicable to TA–W–81,045 is hereby issued as follows: Dow Jones & Company, Inc., Dow Jones Content Services Including OnSite Workers From Aerotek, Inc., Princeton, NJ; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974, as amended (‘‘Act’’), 19 U.S.C. 2273, the Department of Labor issued a Certification of Eligibility to Apply for Worker Adjustment Assistance on January 26, 2012, applicable to workers of Aerotek, Inc., working on-site at Dow Jones Corporation, Dow Jones Content Services Princeton, New Jersey. The workers are engaged in activities related to the production of digital newsletters. The notice was published in the Federal Register on February 8, 2012 (77 FR 6590). At the request of the New Jersey State agency, the Department reviewed the certification for workers of the subject firm. New information shows that workers of the Princeton, New Jersey location of Dow Jones & Company, Dow Jones Content Services, including onsite workers from Aerotek were engaged in activities supporting the production of digital newsletters, both experienced worker separations during the relevant time period due to the shift in the production of digital newsletters to Sophia, Bulgaria. Accordingly, the Department is amending the certification to include workers of the Princeton, New Jersey PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 Employment and Training Administration [TA–W–81,038] Ford Motor Company Twin Cities Assembly Plant Vehicle Operations Division Including On-Site Leased Workers From AEROTEK, Albers Mechanical, Alliedbarton, Allied Systems Aristeo, Autoport Collins Electric, Guardsmark, Great Western Recycling, Healthsource Solutiions, Kelly Services, Marsden Building Maintenance, Penski Logistics Ppg Industries, Waste Management, VMX, Nascote Industries, Delphi Electronics & Safety, Unicomm, And Pacer International St. Paul, MN; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974, as amended (‘‘Act’’), 19 U.S.C. 2273, the Department of Labor issued a Certification of Eligibility to Apply for Worker Adjustment Assistance on February 9, 2012, applicable to workers of Ford Motor Company, Twin Cities Assembly Plant, Vehicle Operations Division, St. Paul, Minnesota. The workers are engaged in activities related to the production of pickup trucks. The notice was published in the Federal Register on February 28, 2012 (77 FR 12083). At the request of the Minnesota State agency, the Department reviewed the certification for workers of the subject firm. New information from the E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Pages 19717-19718]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7759]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 17, 2012, Cerilliant 
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of the following basic classes 
of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-methyl-N-methylcathinone (1248)..........  I
3,4-methylenedioxypyrovalerone (7535)......  I
3,4-methylenedioxy-N-methylcathinone (7540)  I
Desomorphine (9055)........................  I
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards which will be 
distributed to their customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 1, 2012.


[[Page 19718]]


     Dated: March 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-7759 Filed 3-30-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.